We are now able to focus and invest in the future of our technologies.
FORT WORTH, Texas (PRWEB) March 10, 2020
Lifecycle Biotechnologies announced today that is has acquired a 20,000 square foot manufacturing facility on 13 acres in Cleburne, Texas to be used as a biopharmaceutical and biotechnology production and development campus. Lifecycle is currently updating the facility to serve as its global headquarters and sales offices as well as its production and development hub. The company expects to relocate from Fort Worth, Texas by Q3 2020. Lifecycle also plans to build an additional 30,000 square feet on the property to be used as its warehouse and development laboratory for expanding its current operations.
“With our recent divestment of our protein company, we are now able to focus and invest in the future of our technologies," said Cody Yarborough, CEO for Lifecycle Biotechnologies. “We are intimate with multiple life science markets, especially biopharmaceuticals, regenerative medicine, and cellular agriculture and have several products we are launching over the next 36 months. We just don’t have the space to house the employees and equipment for our innovative manufacturing at our current sites and I want to have our leaders hands-on. The city of Cleburne has been an accommodating partner, so I want to invest here.”
Ronald Gohdes, VP of Engineering, added “This will be a unique facility in that the production area is designed to quickly pivot to changing manufacturing schemes due to market needs while under strict controls. We will not only house our chemical, reagent, and media operations, but also include precision packaging of sensitive powdered biochemicals and bring with it the addition of cell culture capabilities.”
Further plans regarding how Lifecycle will expand its current capabilities in Loveland, Colorado and in San Antonio, Texas will be forthcoming. This announcement comes after the company announced the official integration of Chata and VI Plastics to a single, unified company under Lifecycle Biotechnologies earlier this year. This new facility along with the recent integration will create a seamless experience for all of Lifecycle’s partners, system wide, and will ensure access to the quality, service, and expertise expected from Lifecycle.
To learn more about Lifecycle Biotechnologies, the industries it serves, or to learn more about this new location and how to benefit from it, please contact Lifecycle Biotechnologies at firstname.lastname@example.org, 817.840.7855, or http://www.lifecyclebio.com. You can also find more information in the 2020 Lifecycle Prospectus.
Lifecycle Biotechnologies has served the life science industry for over 40 years. Lifecycle’s products are the beginning of the lifecycle of the lifesaving and life-enhancing medical products used globally today. As a leading life sciences tools and service supplier, Lifecycle fully understands the critical role its products play in many of the world’s leading pharmaceuticals, medical devices, biologics, diagnostics, cellular agriculture, cell- and tissue-based products, and many other medical products. While Lifecycle’s products aren’t used to diagnose, treat, or cure patients, without their contribution, none of this would be possible.